Lycopodine

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Lycopodine 

Lycopodine,一种石松 (Lycopodium clavatumspores) 孢子重要的生物活性成分,通过调节难治性前列腺癌细胞中 5-脂氧合酶 (5-lipoxygenase),极化线粒体膜电位而不调节 p53 活性来诱导细胞凋亡。 Lycopodine 通过激活 caspase-3 诱导细胞凋亡来抑制 HeLa 细胞的增殖。

Lycopodine

Lycopodine Chemical Structure

CAS No. : 466-61-5

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Lycopodine, a pharmacologically important bioactive component derived from Lycopodium clavatumspores, triggers apoptosis by modulating 5-lipoxygenase, and depolarizing mitochondrial membrane potential in refractory prostate cancer cells without modulating p53 activity[1]. Lycopodine inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation[2].

IC50 & Target[2]

Caspase-3

 

5-Lipoxygenase

 

体外研究
(In Vitro)

Lycopodine (5.22-78.3 μg/mL; 12 hours) has 50% viability at 57.62±0.086 μg/mL and 51.46±1.43 μg/mL for PC3 and LnCaP, respectively[1].
Treated with Lycopodine (74-222 mM; 12 hours), the apoptotic index is with respect to the gradual increase in doses for the PC3 and LnCaP cells[1].
Lycopodine (74-222 mM; 12 hours) induces cell cycle arrest at G0/G1 phase in PC3 and LnCaP cells[1].
Lycopodine (0-200 µg/mL; 48 hours) shows cytotoxicity to HeLa cells in a dose and time dependent manner. However, Lycopodine shows minimal cytotoxic effects in normal peripheral blood mononuclear cells (PBMC) even at the highest dose (200 µg/mL)[2].
Lycopodine (100, 200 µg/mL; 24 hours) increases level of Bax and decreases the mitochondrial cytochrome c. This is followed by an increase in expression of cytochrome c in cytosolic fraction. Lycopodine also cleaves the caspase-3 in the total cell lysate, while the expression of Bcl-2 is down regulated[2].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: PC3 and LnCaP cells
Concentration: 5.22-78.3 μg/mL
Incubation Time: 12 hours
Result: Reached 50% viability at 57.62±0.086 μg/mL and 51.46±1.43 μg/mL for PC3 and LnCaP, respectively.

Apoptosis Analysis[1]

Cell Line: PC3 and LnCaP cells
Concentration: 74, 148, 222 mM
Incubation Time: 12 hours
Result: The apoptotic index was with respect to the gradual increase in doses.

Cell Cycle Analysis[1]

Cell Line: PC3 and LnCaP cells
Concentration: 74, 148, 222 mM
Incubation Time: 12 hours
Result: Arrested growth of the cells at G0/G1 phase in the case of PC3 and LnCaP cells.

Cell Cytotoxicity Assay[2]

Cell Line: Hela cells and PBMC
Concentration: 0-200 µg/mL
Incubation Time: 48 hours
Result: A linear increase of the cytotoxicity was along with the increase of time of treatment and also of the dose.

Western Blot Analysis[2]

Cell Line: HeLa cells
Concentration: 100, 200 µg/mL
Incubation Time: 24 hours
Result: Increased level of Bax and decreased the mitochondrial cytochrome c.

分子量

247.38

Formula

C16H25NO

CAS 号

466-61-5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Bishayee K, et al. Lycopodine triggers apoptosis by modulating 5-lipoxygenase, and depolarizing mitochondrial membrane potential in androgen sensitive and refractory prostate cancer cells without modulating p53 activity: signaling cascade and drug-DNA interaction. Eur J Pharmacol. 2013 Jan 5;698(1-3):110-21.

    [2]. Mandal SK, et al. Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur J Pharmacol. 2010 Jan 25;626(2-3):115-22.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务